Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.2 USD | +0.33% | +1.74% | +42.06% |
05-31 | Piper Sandler Initiates Immunome With Overweight Rating, $27 Price Target | MT |
05-21 | Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.06% | 912M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- IMNM Stock
- News Immunome, Inc.
- Chardan Adjusts Immunome's Price Target to $9 From $16, Citing IMM-BCP-01 Launch Expectations, Stock Dilution From Future Capital Raises; Buy Rating Kept